Maternal urinary free fl-subunit of human chorionic gonadotrophin: Creatinine ratios and fetal chromosomal abnormalities in the second trimester of pregnancy

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 103, Issue 6, 1996, Pages 577-580

  Hayashi, Meicho ^a   Kozu, Hiromu ^a   Takei, Hitoshi ^a  

^a ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHORIONIC GONADOTROPIN; CREATININE;

ARTICLE; CHROMOSOME ABERRATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOWN SYNDROME; FEMALE; FETUS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; URINALYSIS;

ADULT; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 18; CHROMOSOMES, HUMAN, PAIR 21; FEMALE; GESTATIONAL AGE; HUMANS; KARYOTYPING; PREGNANCY; PREGNANCY TRIMESTER, THIRD; PRENATAL DIAGNOSIS; TRISOMY; TURNER SYNDROME;

EID: 0030029473     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1996.tb09810.x     Document Type: Article

References (12)

1. Wald N, Cuckle HS, Densem JW et al. Maternal serum screening for Down's syndrome in early pregnancy. BMJ 1988; 297: 883–887.
2. Macri JN, Kasturi RV, Krantz DA et al. Maternal serum Down syndrome screening: free β-protein is a more effective marker than human chorionic gonadotropin. Am J Obstet Gynecol 1990; 163: 1248–1253.
3. Norman RJ, Poulton T, Gard T, Chard T. Monoclonal antibodies to human chorionic gonadotropin: implications for antigenic mapping, immunoradiometric assays, and clinical application. J Clin Endocrinol Metub 1985; 61: 1031–1038.
4. Cole LA, Schwartz PE, Wang Y. Urinary gonadotropin fragments (UGF) in cancers of the female reproductive system. I. Sensitivity and specificity, comparison with other markers. Gynecol Oncol 1988; 3: 82–90.
5. Cuckle HS, Iles RK, Chard T. Urinary β-core human gonadotropin: a new approach to Down's syndrome screening. Prenat Diugn 1994; 14: 953–958.
6. Hayashi M, Kozu H. Maternal urinary β-core fragment of hCG/creatinine ratios and fetal chromosomal abnormalities in the second trimester of pregnancy. Prenat Diugn 1995; 15: 11–16.
7. Alfthan H, Haglund C, Roberts P, Stenman U-H. Elevation of free β subunit of human choriogonadotropin and core p fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease. Cancer Res 1992; 52: 4628–4633.
8. Light PA, Forster JP, Felton T, Ekkert H, Tovey KC. Molecular heterogeneity in chorionic gonadotropin in some testicular cancer patients. Lancet 1983; 1: 1284.
9. Khazaili MB, Hedayat MM, Hatch KD et al. Radioimmunoassay of free beta subunit of human chorionic gonadotropin as a prognostic test for persistent trophoblastic disease in molar pregnancy Am J Obstet Gynecol 1986; 155: 320–324.
10. Bogart MH, Pandian MR, Jones OW. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn 1987; 7: 623–630.
11. Burton BK, Prins GS, Verp MS. A prospective trial of prenatal screening for Down's syndrome by means of maternal serum a-fetoprotein, human chorionic gonadotropin, and unconjugated estriol. Am J Obster Gynecol 1993; 169: 526–530.
12. De Medeiros SF, Amato F, Norman RJ. Stability of immunoreactive β-core fragment of hCG. Obstet Gynecol 1991; 77: 53–59.